Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Impact of Minor Structural Modifications on Properties of a Series of mTOR Inhibitors.

Ouvry G, Clary L, Tomas L, Aurelly M, Bonnary L, Borde E, Bouix-Peter C, Chantalat L, Defoin-Platel C, Deret S, Forissier M, Harris CS, Isabet T, Lamy L, Luzy AP, Pascau J, Soulet C, Taddei A, Taquet N, Thoreau E, Varvier E, Vial E, Hennequin LF.

ACS Med Chem Lett. 2019 Oct 4;10(11):1561-1567. doi: 10.1021/acsmedchemlett.9b00401. eCollection 2019 Nov 14.

PMID:
31749911
2.

A Subset of Type I Conventional Dendritic Cells Controls Cutaneous Bacterial Infections through VEGFα-Mediated Recruitment of Neutrophils.

Janela B, Patel AA, Lau MC, Goh CC, Msallam R, Kong WT, Fehlings M, Hubert S, Lum J, Simoni Y, Malleret B, Zolezzi F, Chen J, Poidinger M, Satpathy AT, Briseno C, Wohn C, Malissen B, Murphy KM, Maini AA, Vanhoutte L, Guilliams M, Vial E, Hennequin L, Newell E, Ng LG, Musette P, Yona S, Hacini-Rachinel F, Ginhoux F.

Immunity. 2019 Apr 16;50(4):1069-1083.e8. doi: 10.1016/j.immuni.2019.03.001. Epub 2019 Mar 27.

PMID:
30926233
3.

Atypical Cowpox Virus Infection in Smallpox-Vaccinated Patient, France.

Andreani J, Arnault JP, Bou Khalil JY, Abrahão J, Tomei E, Vial E, Le Bideau M, Raoult D, La Scola B.

Emerg Infect Dis. 2019 Feb;25(2):212-219. doi: 10.3201/eid2502.171433.

4.

Brimonidine displays anti-inflammatory properties in the skin through the modulation of the vascular barrier function.

Bertino B, Blanchet-Réthoré S, Thibaut de Ménonville S, Reynier P, Méhul B, Bogouch A, Gamboa B, Dugaret AS, Zugaj D, Petit L, Roquet M, Piwnica D, Vial E, Bourdès V, Voegel JJ, Nonne C.

Exp Dermatol. 2018 Dec;27(12):1378-1387. doi: 10.1111/exd.13793.

PMID:
30290018
5.

Temporalis, a generic method and tool for dynamic Life Cycle Assessment.

Cardellini G, Mutel CL, Vial E, Muys B.

Sci Total Environ. 2018 Dec 15;645:585-595. doi: 10.1016/j.scitotenv.2018.07.044. Epub 2018 Jul 18.

PMID:
30029133
6.

Nonclinical and human pharmacology of the potent and selective topical retinoic acid receptor-γ agonist trifarotene.

Aubert J, Piwnica D, Bertino B, Blanchet-Réthoré S, Carlavan I, Déret S, Dreno B, Gamboa B, Jomard A, Luzy AP, Mauvais P, Mounier C, Pascau J, Pelisson I, Portal T, Rivier M, Rossio P, Thoreau E, Vial E, Voegel JJ.

Br J Dermatol. 2018 Aug;179(2):442-456. doi: 10.1111/bjd.16719. Epub 2018 Jul 4.

PMID:
29974453
7.

Sulfoximines as potent RORγ inverse agonists.

Ouvry G, Bihl F, Bouix-Peter C, Christin O, Defoin-Platel C, Deret S, Feret C, Froude D, Hacini-Rachinel F, Harris CS, Hervouet C, Lafitte G, Luzy AP, Musicki B, Orfila D, Parnet V, Pascau C, Pascau J, Pierre R, Raffin C, Rossio P, Spiesse D, Taquet N, Thoreau E, Vatinel R, Vial E, Hennequin LF.

Bioorg Med Chem Lett. 2018 May 1;28(8):1269-1273. doi: 10.1016/j.bmcl.2018.03.041. Epub 2018 Mar 17.

PMID:
29571573
8.

EFO-LCI: A New Life Cycle Inventory Database of Forestry Operations in Europe.

Cardellini G, Valada T, Cornillier C, Vial E, Dragoi M, Goudiaby V, Mues V, Lasserre B, Gruchala A, Rørstad PK, Neumann M, Svoboda M, Sirgmets R, Näsärö OP, Mohren F, Achten WMJ, Vranken L, Muys B.

Environ Manage. 2018 Jun;61(6):1031-1047. doi: 10.1007/s00267-018-1024-7. Epub 2018 Mar 20.

PMID:
29560524
9.

Discovery and Characterization of CD12681, a Potent RORγ Inverse Agonist, Preclinical Candidate for the Topical Treatment of Psoriasis.

Ouvry G, Atrux-Tallau N, Bihl F, Bondu A, Bouix-Peter C, Carlavan I, Christin O, Cuadrado MJ, Defoin-Platel C, Deret S, Duvert D, Feret C, Forissier M, Fournier JF, Froude D, Hacini-Rachinel F, Harris CS, Hervouet C, Huguet H, Lafitte G, Luzy AP, Musicki B, Orfila D, Ozello B, Pascau C, Pascau J, Parnet V, Peluchon G, Pierre R, Piwnica D, Raffin C, Rossio P, Spiesse D, Taquet N, Thoreau E, Vatinel R, Vial E, Hennequin LF.

ChemMedChem. 2018 Feb 20;13(4):321-337. doi: 10.1002/cmdc.201700758. Epub 2018 Feb 6.

PMID:
29327456
10.

Discovery and process development of a novel TACE inhibitor for the topical treatment of psoriasis.

Boiteau JG, Ouvry G, Arlabosse JM, Astri S, Beillard A, Bhurruth-Alcor Y, Bonnary L, Bouix-Peter C, Bouquet K, Bourotte M, Cardinaud I, Comino C, Deprez B, Duvert D, Féret A, Hacini-Rachinel F, Harris CS, Luzy AP, Mathieu A, Millois C, Orsini N, Pascau J, Pinto A, Piwnica D, Polge G, Reitz A, Reversé K, Rodeville N, Rossio P, Spiesse D, Tabet S, Taquet N, Tomas L, Vial E, Hennequin LF.

Bioorg Med Chem. 2018 Feb 15;26(4):945-956. doi: 10.1016/j.bmc.2017.07.054. Epub 2017 Aug 2.

PMID:
28818461
11.

Topical ivermectin improves allergic skin inflammation.

Ventre E, Rozières A, Lenief V, Albert F, Rossio P, Laoubi L, Dombrowicz D, Staels B, Ulmann L, Julia V, Vial E, Jomard A, Hacini-Rachinel F, Nicolas JF, Vocanson M.

Allergy. 2017 Aug;72(8):1212-1221. doi: 10.1111/all.13118. Epub 2017 Feb 6.

PMID:
28052336
12.

Protective Effect of Dermal Brimonidine Applications Against UV Radiation-induced Skin Tumors, Epidermal Hyperplasia and Cell Proliferation in the Skin of Hairless Mice.

Bouvier G, Learn DB, Nonne C, Feraille G, Vial E, Ruty B.

Photochem Photobiol. 2015 Nov;91(6):1479-87. doi: 10.1111/php.12528. Epub 2015 Oct 14.

PMID:
26333507
13.

Will selenium increase lentil (Lens culinaris Medik) yield and seed quality?

Thavarajah D, Thavarajah P, Vial E, Gebhardt M, Lacher C, Kumar S, Combs GF.

Front Plant Sci. 2015 May 19;6:356. doi: 10.3389/fpls.2015.00356. eCollection 2015.

14.

Combining two repurposed drugs as a promising approach for Alzheimer's disease therapy.

Chumakov I, Nabirotchkin S, Cholet N, Milet A, Boucard A, Toulorge D, Pereira Y, Graudens E, Traoré S, Foucquier J, Guedj M, Vial E, Callizot N, Steinschneider R, Maurice T, Bertrand V, Scart-Grès C, Hajj R, Cohen D.

Sci Rep. 2015 Jan 8;5:7608. doi: 10.1038/srep07608.

15.

Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy.

Chumakov I, Milet A, Cholet N, Primas G, Boucard A, Pereira Y, Graudens E, Mandel J, Laffaire J, Foucquier J, Glibert F, Bertrand V, Nave KA, Sereda MW, Vial E, Guedj M, Hajj R, Nabirotchkin S, Cohen D.

Orphanet J Rare Dis. 2014 Dec 10;9:201. doi: 10.1186/s13023-014-0201-x.

16.

[Urban violence and social capital in a southern Brazilian city: a quantitative and qualitative study].

Vial EA, Junges JR, Olinto MT, Machado PS, Pattussi MP.

Rev Panam Salud Publica. 2010 Oct;28(4):289-97. Portuguese.

PMID:
21152717
17.

[Prevalence of poor self-rated mastication and associated factors in Brazilian elderly].

Dias-da-Costa JS, Galli R, Oliveira EA, Backes V, Vial EA, Canuto R, Souza LL, Cremonese C, Olinto MT, Pattussi MP, Triches JM.

Cad Saude Publica. 2010 Jan;26(1):79-88. Portuguese.

18.

Major contribution of MEK1 to the activation of ERK1/ERK2 and to the growth of LS174T colon carcinoma cells.

Shama J, Garcia-Medina R, Pouysségur J, Vial E.

Biochem Biophys Res Commun. 2008 Aug 8;372(4):845-9. doi: 10.1016/j.bbrc.2008.05.135. Epub 2008 Jun 3.

PMID:
18533112
19.

Smurf1 regulates tumor cell plasticity and motility through degradation of RhoA leading to localized inhibition of contractility.

Sahai E, Garcia-Medina R, Pouysségur J, Vial E.

J Cell Biol. 2007 Jan 1;176(1):35-42. Epub 2006 Dec 26.

20.

[Nursing in life re-significance on the face of disease].

Selli L, Vial EA, Junges JR.

Rev Bras Enferm. 2005 Jan-Feb;58(1):82-5. Portuguese.

PMID:
16268290
22.
23.

v-Jun downregulates the SPARC target gene by binding to the proximal promoter indirectly through Sp1/3.

Chamboredon S, Briggs J, Vial E, Hurault J, Galvagni F, Oliviero S, Bos T, Castellazzi M.

Oncogene. 2003 Jun 26;22(26):4047-61.

PMID:
12821939
24.

Mapping of autosomal recessive chronic distal spinal muscular atrophy to chromosome 11q13.

Viollet L, Barois A, Rebeiz JG, Rifai Z, Burlet P, Zarhrate M, Vial E, Dessainte M, Estournet B, Kleinknecht B, Pearn J, Adams RD, Urtizberea JA, Cros DP, Bushby K, Munnich A, Lefebvre S.

Ann Neurol. 2002 May;51(5):585-92.

PMID:
12112104
25.
26.

The defective transforming phenotype of c-Jun Ala(63/73) is rescued by mutation of the C-terminal phosphorylation site.

Bost F, Caron L, Vial E, Montreau N, Marchetti I, Dejong V, Defize L, Castellazzi M, Binétruy B.

Oncogene. 2001 Nov 1;20(50):7425-9.

27.

Detection of heterozygous SMN1 deletions in SMA families using a simple fluorescent multiplex PCR method.

Saugier-Veber P, Drouot N, Lefebvre S, Charbonnier F, Vial E, Munnich A, Frébourg T.

J Med Genet. 2001 Apr;38(4):240-3. No abstract available.

28.
29.
31.

Biochemical, genetic and immunoblot analyses of 17 patients with an isolated cytochrome c oxidase deficiency.

von Kleist-Retzow JC, Vial E, Chantrel-Groussard K, Rötig A, Munnich A, Rustin P, Taanman JW.

Biochim Biophys Acta. 1999 Sep 20;1455(1):35-44.

32.

Reconstitution of caspase-mediated cell-death signalling in Schizosaccharomyces pombe.

Ryser S, Vial E, Magnenat E, Schlegel W, Maundrell K.

Curr Genet. 1999 Aug;36(1-2):21-8.

PMID:
10447591
33.

Autocrine growth and anchorage independence: two complementing Jun-controlled genetic programs of cellular transformation.

van Dam H, Huguier S, Kooistra K, Baguet J, Vial E, van der Eb AJ, Herrlich P, Angel P, Castellazzi M.

Genes Dev. 1998 Apr 15;12(8):1227-39.

35.

Source of the colours produced in tissue slices with the MBTH reaction colour sources.

Horvath A, Gonzalez E, Farias G, Cabrera R, Parraguez O, Vial E.

Acta Anat (Basel). 1983;115(3):238-43. No abstract available.

PMID:
6845962
36.

Staining of collagen and elastin in tissue slices with the methyl-benzothiazol-2-on-hydrazone reagent.

Horvath A, Cabrera R, Vial E.

Acta Anat (Basel). 1981;111(4):314-9.

PMID:
6172949
37.

Observations on the histogenesis of bovine ruminal papillae.

Arias JL, Vial E, Cabrera R.

Am J Vet Res. 1980 Feb;41(2):174-8.

PMID:
7369589

Supplemental Content

Support Center